Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-833,118
Closed -$25.2M 3819
2025
Q4
$25.2M Sell
833,118
-1,425
-0.2% -$35K 0.01% 776
2025
Q3
$16.5M Sell
834,543
-350,369
-30% -$7.33M ﹤0.01% 896
2025
Q2
$29.5M Sell
1,184,912
-19,217
-2% -$433K 0.01% 892
2025
Q1
$28.2M Buy
1,204,129
+43,050
+4% +$1.25M 0.01% 828
2024
Q4
$32.5M Buy
1,161,079
+114,701
+11% +$3.07M 0.01% 782
2024
Q3
$21.3M Sell
1,046,378
-539,530
-34% -$12.1M 0.01% 919
2024
Q2
$46.8M Buy
1,585,908
+471,529
+42% +$13.5M 0.01% 632
2024
Q1
$34M Buy
1,114,379
+39,572
+4% +$1.12M 0.01% 673
2023
Q4
$25.2M Buy
1,074,807
+206,399
+24% +$4.99M 0.01% 728
2023
Q3
$25.7M Buy
868,408
+804,292
+1,254% +$27M 0.01% 713
2023
Q2
$1.54M Hold
64,116
﹤0.01% 1795
2023
Q1
$1.54M Hold
64,116
﹤0.01% 1795
2022
Q4
$1.43M Hold
64,116
﹤0.01% 1692
2022
Q3
$1.52M Sell
64,116
-21,923
-25% -$591K ﹤0.01% 1736
2022
Q2
$2M Buy
+86,039
New +$2.32M ﹤0.01% 1613

Other funds holding CFLT

UBS AM's CFLT Position: Q1 2026 in Review

UBS AM sold out of Confluent (CFLT) in Q1 2026, closing a stake of 833,118 shares — an estimated $25.2M sold.

UBS AM first reported a position in CFLT in Q2 2022 and held it in 15 quarters. The position peaked at $46.8M in Q2 2024. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • UBS AM reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • UBS AM sold 833,118 Confluent shares in Q1 2026, an estimated $25.2M.
  • UBS AM first reported a position in Confluent in Q2 2022 and held it in 15 quarters.
  • UBS AM's Confluent position peaked at $46.8M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.